Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding


This week's local life sciences industry news includes details on a Philadelphia biotech company achieving an FDA first, a gift that will expand treatment options at a local ALS center, and more.

Previous Upscale raw bar and cantina Omakase Por Favor joining Lincoln's Terra Cotta Village
Next Why Pittsburgh biotech company Carmell Therapeutics is going public